Targeting HE4 for treatment of endometrial cancer using a novel small molecule inhibitor. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full ...
As artificial intelligence technology continues to improve, more companies have become interested in machine learning—technology that is able to “learn” and adapt to become increasingly adept at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback